Literature DB >> 9393586

Differential expressions of cyclin A and the retinoblastoma gene product in histological subtypes of lung cancer cell lines.

E Shimizu1, M Zhao, A Shinohara, O Namikawa, T Ogura, N Masuda, M Takada, M Fukuoka, S Sone.   

Abstract

Cell-cycle-dependent phosphorylation of the tumor-suppressor protein product of the retinoblastoma gene (RB) is mediated by a family of cyclin-dependent kinases and cyclins. We examined the expressions of RB protein and cyclin A protein in 13 small-cell lung cancer (SCLC) lines and 14 non-small-cell lung cancer (NSCLC) lines by immunoblotting. RB protein was not present or was of a mutant type in 77% of the SCLC lines (10/13) but was present in all the NSCLC lines. Cyclin A was expressed in 38% of the SCLC lines (5/13) and in 86% of the NSCLC lines (12/14). A positive correlation (P = 0.0034) between expression of cyclin A and wild-type RB protein was found by Fisher's exact probability test. Densitometric analysis of the expression of RB protein in RB(+) lung cancer lines showed that the phosphorylated form was predominant in 2/3 of the SCLC and 8/14 of the NSCLC lines. The positive correlation between the expressions of RB protein and cyclin A suggests that RB protein in most RB(+) lung cancer cell lines is a target of cyclin-A-dependent kinase and that the tumor-suppressor function may be inactivated by phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9393586     DOI: 10.1007/s004320050101

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  2 in total

Review 1.  Molecular biology of lung cancer: clinical implications.

Authors:  Jill E Larsen; John D Minna
Journal:  Clin Chest Med       Date:  2011-10-07       Impact factor: 2.878

2.  64Cu-ATSM Predicts Efficacy of Carbon Ion Radiotherapy Associated with Cellular Antioxidant Capacity.

Authors:  Ankita Nachankar; Takahiro Oike; Hirofumi Hanaoka; Ayaka Kanai; Hiro Sato; Yukari Yoshida; Hideru Obinata; Makoto Sakai; Naoto Osu; Yuka Hirota; Akihisa Takahashi; Atsushi Shibata; Tatsuya Ohno
Journal:  Cancers (Basel)       Date:  2021-12-07       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.